Orange County Bio

🌟 We’re excited to announce that Orange County Bio is proudly sponsoring The Leadership & Professional Development Award at The Advanced Therapies Awards! This prestigious award recognizes cell and gene therapy firms that are shaping the future by investing in their people and building strong leaders. If your organization is committed to fostering leadership through innovative development programs, both internally and externally, we encourage you to apply. Apply here: https://lnkd.in/erxJV5pe #OCBio, #OrangeCountyBio, #CGT, #CellandGeneTherapy, #CellTherapy, #GeneTherapy, #Consulting, #Marketing, #ATW, #leadership

🔬 Unlocking New Horizons in Pediatric Cell and Gene Therapy In the rapidly evolving field of Cell and Gene Therapies (CGTs), there’s an urgent need to address the unique challenges in treating pediatric diseases. The traditional biopharmaceutical model often falls short in delivering these life-saving treatments to children due to small market sizes, high manufacturing costs, and regulatory hurdles. Curious about how this could transform the landscape of pediatric healthcare? Dive into the full article to explore the potential solutions that could make a difference in the lives of countless children Read full article here: https://lnkd.in/g97E-5at #OCBio, #OrangeCountyBio, #CGT, #CellandGeneTherapy, #CellTherapy, #GeneTherapy, #Consulting, #Marketing

🚀 Dive into our latest blog post where we explore the critical process of Mapping Your DNA and its profound significance in understanding the essence of your business. Discover how our comprehensive and client-focused Mapping Your DNA lays the groundwork for informed decision-making and strategic planning, empowering you to better connect with your target audiences, engage customers, and stand out in the dynamic Cell and Gene Therapy marketplace. Don't miss out on unlocking the key to strategic success! Read the full post here: https://lnkd.in/gGUa5M73 #OCBio, #OrangeCountyBio, #CGT, #CellandGeneTherapy, #CellTherapy, #GeneTherapy, #Consulting, #Marketing, #MappingYourDNA

🚨 Don't Miss This Opportunity! The FDA's Center for Biologics Evaluation and Research Office of Therapeutic Products is hosting a Virtual Town Hall on September 5, 2024. This event is a must-attend for anyone involved in Cell Therapy and tissue-engineered products. This town hall is your chance to get expert insights and answers directly from the FDA's Office of Cellular Therapy and Human Tissue CMC. Whether you're a sponsor or stakeholder in the cell and gene therapy space, this is a great opportunity to ensure your CMC data is on point. Don’t miss the chance to stay ahead in the regulatory landscape! #OCBio, #OrangeCountyBio, #CGT, #CellandGeneTherapy, #CellTherapy, #GeneTherapy, #Consulting, #Marketing

CAR-T therapies, traditionally used to treat blood cancers, are now being explored for autoimmune diseases. A recent article highlighted the pioneering efforts of biotech companies in using CAR-T cells to target conditions like multiple sclerosis and systemic lupus erythematosus (SLE). Early clinical findings are promising, showcasing the potential for CAR-T cells to offer new, effective treatments for these challenging disorders. Read more here: https://lnkd.in/eQ9UKbSd #OCBio, #OrangeCountyBio, #CGT, #CellandGeneTherapy, #CellTherapy, #GeneTherapy, #Consulting, #Marketing, #autoimmuedisease, #SLE, #lupus

🚨 Exciting News! 🚨 Adaptimmune has achieved a major milestone with the FDA's accelerated approval of Tecelra, the first engineered cell therapy for solid tumors. This groundbreaking therapy targets metastatic or unresectable synovial sarcoma and represents the first TCR-T therapy on the market, marking a new era in cell therapy. Tecelra’s approval is a significant milestone in the CGT field. It demonstrates the potential of engineered cell therapies to effectively target and treat solid tumors, paving the way for future innovations. Read more here: https://lnkd.in/ekxia_YV #OCBio, #OrangeCountyBio, #CGT, #CellandGeneTherapy, #CellTherapy, #GeneTherapy, #Consulting, #Marketing, #TCR, #solidtumor

🔬 Groundbreaking Development in Allogeneic CAR-T Therapy! 🔬 A recent study published in Cell [tag] marks a significant milestone in the treatment of autoimmune diseases with allogeneic CAR-T therapy. For the first time, researchers have successfully used "off-the-shelf" CAR-T cells to treat autoimmune diseases, showcasing remarkable results in three patients. This pioneering research highlights the potential of engineered CAR-T cells targeting CD19 to achieve remission and improve the quality of life in patients with immune-mediated necrotizing myopathy and diffuse cutaneous systemic sclerosis. This breakthrough paves the way for future advancements in CAR-T therapies for autoimmune conditions. Read full article here: https://lnkd.in/g5HKS3ud #OCBio, #OrangeCountyBio, #CGT, #CellandGeneTherapy, #CellTherapy, #GeneTherapy, #Consulting, #Marketing

Quality control is a cornerstone of success in the cell and gene therapy (CGT) field, ensuring safety and efficacy in groundbreaking treatments. Discover how innovative technologies are transforming traditional protocols, drastically reducing turnaround times and enhancing the precision of replication competent virus testing. Click the link below to explore the latest advancements in quality control for lentivirus and AAV vectors. https://lnkd.in/g4T7qShf #OCBio, #OrangeCountyBio, #CGT, #CellandGeneTherapy, #CellTherapy, #GeneTherapy, #Consulting, #Marketing, #QC, #vector, #AAV

The FDA’s Center for Biologics Evaluation and Research (CBER) has launched the Cellular and Gene Therapies Interactive Site Tours Program. This initiative offers CBER regulatory project managers and reviewers the chance to tour biotechnology manufacturing facilities and exchange regulatory experiences with industry counterparts. The program aims to enhance review efficiency and quality by giving FDA staff a better understanding of the biotech industry's operations. Companies developing cellular and gene therapy products are invited to participate and submit proposed agendas by August 14, 2024. This initiative represents a significant opportunity for industry engagement and regulatory insight. Read more here: https://lnkd.in/gsA3x_K3 #OCBio, #OrangeCountyBio, #CGT, #CellandGeneTherapy, #CellTherapy, #GeneTherapy, #Consulting, #Marketing

🚀 Discover the Power of Strong Branding in the CGT Industry! In the rapidly evolving world of Cell and Gene Therapy (CGT), standing out can be a challenge. Our latest blog post explores how good branding can demystify complex scientific concepts, instill confidence in partners and regulators, and build trust within and outside the organization. Don’t miss out on these valuable insights—read the full blog post now and unlock the secrets to building a strong brand in the CGT industry. https://lnkd.in/ggb3Yea5 #OCBio, #OrangeCountyBio, #CGT, #CellandGeneTherapy, #CellTherapy, #GeneTherapy, #Consulting, #Marketing, #Branding, #Brand